Branden S Moriarity Selected Research

Branden S Moriarity Research Topics

Disease

23	Neoplasms (Cancer) 11/2022 - 01/2013
6	Osteosarcoma (Osteogenic Sarcoma) 12/2020 - 06/2015
4	Neoplasm Metastasis (Metastasis) 12/2020 - 12/2016
3	Neurofibrosarcoma (MPNST) 03/2021 - 07/2013
2	Hypertrophy 01/2022 - 04/2021
2	Infections 01/2021 - 11/2020
2	Inflammation (Inflammations) 01/2021 - 01/2019
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 01/2021
2	Medulloblastoma 01/2019 - 01/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2016 - 08/2014
1	Autoimmune Diseases (Autoimmune Disease) 04/2022
1	Glomerulonephritis 04/2022
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022
1	Cardiac Arrhythmias (Arrythmia) 01/2022
1	Cytokine Release Syndrome 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Fever (Fevers) 01/2021
1	Carcinogenesis 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 11/2019
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2019
1	Liver Neoplasms (Liver Cancer) 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Primitive Neuroectodermal Tumors (PNET) 01/2019
1	Basal Cell Nevus Syndrome (Gorlin Syndrome) 01/2019
1	Chronic Hepatitis B 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Neurofibromatoses (Neurofibromatosis) 07/2013
1	Sarcoma (Soft Tissue Sarcoma) 07/2013
1	Neurofibroma 06/2013
1	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 01/2012

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2013
6	RNA (Ribonucleic Acid)IBA 02/2018 - 08/2014
4	ErbB Receptors (EGF Receptor)IBA 07/2014 - 01/2012
3	CytokinesIBA 11/2022 - 01/2020
2	LigandsIBA 11/2022 - 06/2013
2	CateninsIBA 03/2021 - 06/2013
2	Chimeric Antigen ReceptorsIBA 10/2020 - 08/2018
2	Long Noncoding RNAIBA 01/2017 - 08/2014
2	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2016 - 08/2014
1	B-Cell Activating FactorIBA 11/2022
1	Antinuclear AntibodiesIBA 04/2022
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 01/2022
1	Cardiac MyosinsIBA 01/2022
1	CalciumIBA 01/2022
1	myosin-binding protein CIBA 01/2022
1	Complement System Proteins (Complement)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021
1	NucleosidesIBA 12/2020
1	triciribineIBA 12/2020
1	AntibodiesIBA 11/2020
1	EnzymesIBA 11/2020
1	Biological ProductsIBA 11/2020
1	pexidartinibIBA 01/2020
1	Semaphorins (Semaphorin)IBA 01/2020
1	Arachidonic Acid (Vitamin F)IBA 01/2019
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2019
1	LeukotrienesIBA 01/2019
1	ProstaglandinsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Untranslated RNA (Noncoding RNA)IBA 01/2017
1	GTPase-Activating Proteins (GTPase-Activating Protein)IBA 12/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	CD100 antigenIBA 06/2015
1	TransposasesIBA 02/2015
1	Transcription Activator-Like Effector NucleasesIBA 08/2014
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2012
1	TensinsIBA 01/2012

Therapy/Procedure

7	Therapeutics 01/2021 - 01/2018
6	Immunotherapy 06/2022 - 01/2018
1	Drug Therapy (Chemotherapy) 01/2021
1	Transplantation 01/2019
1	Induction Chemotherapy 11/2016